Addex Therapeutics(ADXN) - 2025 Q2 - Quarterly Report

Addex Therapeutics │ Unaudited Interim Condensed Consolidated Financial Statements Unaudited Interim Condensed Consolidated Balance Sheets as of June 30, 2025, and December 31, 2024 | | | June 30, | December 31, | | --- | --- | --- | --- | | | Notes | 2025 Amounts in Swiss francs | 2024 | | ASSETS | | | | | Current assets | | | | | Cash and cash equivalents | 6 | 2,300,994 | 3,341,738 | | Other financial assets | 7/13 | 6,994 | 6,496 | | Trade and other receivables | 7 | 38,439 | 15,513 | | Prepayments | 7 ...